As a chronic autoimmune disease, the inflammatory condition in rheumatoid arthritis not only enhances bone degradation by raising the crosstalk between osteoclastogenesis and the immune system, but also stimulates TLR2 on osteoblasts and increases the production of RANKL (Kassem et al., 2015). The gene discussed is TNFSF11; the disease is rheumatoid arthritis.